Quentis, an immuno-oncology therapy developer based on research at Weill Cornell Medicine, has closed a round that included Taiho Pharmaceuticals and AbbVie Ventures.

SK Telecom has committed $65m to ID Quantique, a quantum cryptography technology spinout from University of Geneva, adding to $2m it had previously provided.

Collibra, a data governance software spinout of VUB, has closed a $58m series D round to accelerate its expansion plans and product development.

KBP Biosciences, which is developing drugs for disease areas of unmet need, raised the series A funds from investors including Cash Capital.

Northwestern University and Osage University Partners both returned to back a $70m series B for Aptinyx, having previously contributed to a $65m series A round in May 2016.

GV has joined the investors in oncology treatment developer Relay Therapeutics, which has now raised $120m altogether.

NEA has led a series B round for cancer treatment developer Pionyr Immunotherapeutics, co-founded by researchers from UC San Francisco and University of Toronto.

UC-RNT, an investment fund established by University of California and Ratan Tata, has contributed to a funding round for NestAway, whose shareholders already include Flipkart.